Calidi Biotherapeutics Stock (AMEX: CLDI) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 21.695K / 937.366K |
Day Range | - - - |
52 Wk Range | 0.144 - 5.000 |
Market Cap | $9.381M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 35 |
Short Interest | 0.4% |
Days to Cover | 2.81 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Calidi Biotherapeutics (AMEX: CLDI) through any online brokerage.
Other companies in Calidi Biotherapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR) and Coeptis Therapeutics (NASDAQ:COEP).
The latest price target for Calidi Biotherapeutics (AMEX: CLDI) was reported by Baird on Thursday, March 21, 2024. The analyst firm set a price target for 4.50 expecting CLDI to rise to within 12 months (a possible 2248.64% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Calidi Biotherapeutics (AMEX: CLDI) is $0.1916 last updated Today at April 30, 2024 at 6:23 AM EDT.
There are no upcoming dividends for Calidi Biotherapeutics.
Calidi Biotherapeutics’s Q1 earnings are confirmed for Saturday, May 18, 2024.
There is no upcoming split for Calidi Biotherapeutics.
Calidi Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.